Concepedia

Publication | Open Access

Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease

DOIFull Paper Access

88

Citations

41

References

2021

Year

Huntington Potter, Jonathan H. Woodcock, Timothy D. Boyd, Christina Coughlan, John R. O'Shaughnessy, Manuel T. Borges, Ashesh A. Thaker, B A Raj, Katarzyna Adamszuk, David Scott,
Alzheimer s & Dementia Translational Research & Clinical Interventions

Abstract

The innate immune system is a viable target for therapeutic intervention in AD. An extended treatment trial testing the long-term safety and efficacy of GM-CSF/sargramostim in AD is warranted.

References

YearCitations

Page 1